ClinicalTrials.Veeva

Menu

Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure

Q

Qianfoshan Hospital

Status

Not yet enrolling

Conditions

Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT06158711
Qianfoshan HF 2023

Details and patient eligibility

About

The goal of this observational study is to assess the effect of the different combination of drugs in the treatment of heart failure.

The main questions it aims to answer are:

  • [question 1] The changes of BNP and LVEF in patients of each groups with different drugs co-administration.
  • [question 2] The days of hospitalization, degree of lower limb edema (mild, moderate, severe) and 6-minute walking test in each groups.

Participants will be asked to do nothing. All the records of the patients will be download from the Big Data Cloud Platform of Health Care in the First Affiliated Hospital of Shandong First Medical University.

There is not a comparison group.

Full description

The purpose of this study is to evaluate the efficacy and cost-effective of different drugs co-administration in the treatment of heart failure. For different reasons, patients with heart failure took different drug prescriptions. Now there are five kinds of drugs for the treatment of heart failure, such as angiotensin converting enzyme inhibitor or angiotensin receptor blocker (ACEI/ARB), beta-blokers, spironolactone, sodium-glucose cotransporter (sglt) 2 inhibitors and vericiguat. Our purpose is to assessment the efficacy and cost-effective of different drugs co-administration in the treatment of heart failure.

Enrollment

702 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed as "heart failure" or "cardiac insufficiency" on the first page of the medical record

Exclusion criteria

  • Severe impairment of liver, kidney and lung function (transaminase increased more than 2 times; Scr > 265umol/L); malignant tumor

Trial design

702 participants in 1 patient group

single drug group, two drugs group, three drugs group and four drugs group
Description:
single drug group, patients with heart failure only took one sort of drugs two drugs group, patients with heart failure took two sorts of drugs three drugs group, patients with heart failure took three sorts of drugs four drugs group, patients with heart failure took four sorts of drugs

Trial contacts and locations

0

Loading...

Central trial contact

Guang Yang, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems